About Cellular Therapy

 

What Type of Cells Would Be Used?

While there are many options for the type of cells used in the science, the Lung Institute only treats with autologous cells. This means the cells are directly coming from a patient’s own body and are later infused back into the same patient. This decreases the possibility of rejection and eliminates any possible controversy associated with cells.

The Lung Institute offers cellular therapy: bone marrow cellular therapy and Blood-Derived cellular therapy. Depending on the nature of the patient’s condition and health history, the bone marrow therapy is always performed in conjunction with the blood-derived therapy. On the other hand, the blood-derived therapy can be performed on its own when needed. During these therapies, the adult cells go through a specific process to target the damaged tissue.

The Whole Process

The cells are extracted from the patient’s body blood depending on the case. The cells are isolated by a trained professional in a clinical setting. The cells are quickly returned to the patient either intravenously. Now, the cells will begin to promote the healing of lung tissue. With their ability to continually replicate, the lungs grow stronger, and patients are able to breathe easier and live better.

If you or a loved one want to learn more about how adult cellular therapy can be used to combat lung disease, contact us or call us at (800) 729-3065.

 

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.